SWOG clinical trial number
SWOG-9107

A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer

Closed
Phase
Accrual
70%
Published
Abbreviated Title
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer
Activated
01/01/1993
Closed
08/01/1994

Publication Information Expand/Collapse

2004

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

RP Whitehead;JK Benedetti;JL Abbruzzese;B Ardalan;S Williamson;ER Gaynor;SP Balcerzak;JS Macdonald Investigational New Drugs 22:467-473